Omega Therapeutics, Inc.
11
Brendan Linehan Shannon
02/10/2025
02/21/2025
Yes
v
| PlnDue, DsclsDue, STANDOrder, CLMSAGNT |
Assigned to: Brendan Linehan Shannon Chapter 11 Voluntary Asset |
|
Debtor Omega Therapeutics, Inc.
140 First Street Suite 501 Cambridge, MA 02141 MIDDLESEX-MA Tax ID / EIN: 81-3247585 aka VL42, Inc. |
represented by |
Derek C. Abbott
Morris, Nichols, Arsht & Tunnell 1201 N. Market Street P.O. Box 1347 Wilmington, DE 19899 (302) 658-9200 Fax : 302-658-3989 Email: dabbott@mnat.com Luke Brzozowski
Morris Nichols Arsht and Tunnell 1201 North Market Street Ste 1600 Wilmington, DE 19899 302-351-9486 Email: lbrzozowski@morrisnichols.com Daniel B. Butz
Morris, Nichols, Arsht & Tunnell LLP 1201 N. Market Street 16th Floor Wilmington, DE 19801 302-575-7348 Fax : 302-658-3989 Email: dbutz@mnat.com Jonathan Michael Weyand
Morris, Nichols, Arsht and Tunnell 1201 N. Market St. 16th Floor P.O. Box 1347 Wilmington, DE 19899-1347 302-553-5964 Email: jweyand@morrisnichols.com |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
| |
Claims Agent Kroll Restructuring Administration LLC
www.kroll.com/kra 1 World Trade Center 31st Floor New York, NY 10007 |
represented by |
Benjamin Joseph Steele
Kroll Restructuring Administration LLC (F/K/A Prime Clerk LLC) 850 Third Avenue Suite 412 Brooklyn, NY 11232 212-257-5490 Email: bsteele@primeclerk.com |
Transcriber Reliable Companies
Attn: Gene Matthews 1007 North Orange Street Suite 110 Wilmington, DE 19801 302-654-8080 |
| Date Filed | # | Docket Text |
|---|---|---|
| 02/20/2025 | 59 | Notice of Appointment of Creditors' Committee Filed by U.S. Trustee. (Hackman, Benjamin) (Entered: 02/20/2025) |
| 02/19/2025 | 58 | Application/Motion to Employ/Retain Kroll Restructuring Administration LLC as Administrative Advisor Filed by Omega Therapeutics, Inc.. Hearing scheduled for 3/12/2025 at 01:30 PM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #1, Wilmington, Delaware. Objections due by 3/5/2025. (Attachments: # 1 Notice # 2 Exhibit A # 3 Exhibit B # 4 Exhibit C) (Weyand, Jonathan) (Entered: 02/19/2025) |
| 02/19/2025 | 57 | Application/Motion to Employ/Retain Triple P RTS, LLC and Triple P Securities, LLC as Restructuring Advisor and Investment Banker Filed by Omega Therapeutics, Inc.. Hearing scheduled for 3/12/2025 at 01:30 PM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #1, Wilmington, Delaware. Objections due by 3/5/2025. (Attachments: # 1 Notice # 2 Exhibit A # 3 Exhibit B) (Weyand, Jonathan) (Entered: 02/19/2025) |
| 02/19/2025 | 56 | Order Approving Motion for Admission pro hac vice of Beverly Weiss Manne (Related Doc # 55) Order Signed on 2/19/2025. (JMW) (Entered: 02/19/2025) |
| 02/19/2025 | 55 | Motion to Appear pro hac vice (Beverly Weiss Manne). Receipt Number 3728, Filed by Thermo Fisher Scientific. (Hiller, Adam) (Entered: 02/19/2025) |
| 02/19/2025 | 54 | Notice of Appearance. Filed by Thermo Fisher Scientific. (Hiller, Adam) (Entered: 02/19/2025) |
| 02/19/2025 | 53 | Transcript regarding Hearing Held 02/11/25 RE: First Day Motions. Remote electronic access to the transcript is restricted until 5/20/2025. The transcript may be viewed at the Bankruptcy Court Clerk's Office. For information about how to obtain a transcript, call the Clerk's Office or Contact the Court Reporter/Transcriber, Reliable, at Telephone number 302-654-8080. Filed by . Notice of Intent to Request Redaction Deadline Due By 2/26/2025. Redaction Request Due By 3/12/2025. Redacted Transcript Submission Due By 3/24/2025. Transcript access will be restricted through 5/20/2025. (JMC) (Entered: 02/19/2025) |
| 02/17/2025 | 52 | Declaration in Support // Declaration of Steven W. Bremer in Support of the Debtor's Bidding Procedures Motion Filed by Omega Therapeutics, Inc.. (Abbott, Derek) (Entered: 02/17/2025) |
| 02/17/2025 | 51 | Motion to Approve // Debtor's Motion for (I) An Order Pursuant to Sections 105, 363, 364, 365, 503 and 507 of the Bankruptcy Code, Bankruptcy Rules 2002, 6004, 6006 and 9007 and Del. Bankr. L.R. 2002-1 and 6004-1 (A) Approving Bidding Procedures for the Sale of Substantially All of the Debtor's Assets; (B) Approving the Debtor's Entry Into Stalking Horse APA and Related Bid Protections; (C) Approving Procedures for the Assumption and Assignment or Rejection of Designated Executory Contracts and Unexpired Leases; (D) Scheduling an Auction and Sale Hearing; (E) Approving Forms and Manner of Notice of Respective Dates, Times, and Places in Connection Therewith; and (F) Granting Related Relief; (II) An Order (A) Approving the Sale of the Debtor's Assets Free and Clear of Claims, Liens, and Encumbrances; and (B) Approving the Assumption and Assignment of Designated Executory Contracts and Unexpired Leases; and (III) Certain Related Relief Filed by Omega Therapeutics, Inc.. Hearing scheduled for 3/12/2025 at 01:30 PM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #1, Wilmington, Delaware. Objections due by 3/3/2025. (Attachments: # 1 Notice # 2 Exhibit A # 3 Exhibit B) (Abbott, Derek) (Entered: 02/17/2025) |
| 02/14/2025 | 50 | Order Approving Motion for Admission pro hac vice for Richard M. Pachulski. (Related Doc # 47) Order Signed on 2/14/2025. (JMW) (Entered: 02/14/2025) |